Building a category-defining healthcare technology company.
Kihealth is a high-growth platform company commercializing InterceptIQ™ — the AI-powered intelligence engine behind a new era of predictive, preventive healthcare. Multiple growth engines. Multi-trillion-dollar markets. One scalable platform.
InterceptIQ™ — the molecular intelligence platform.
One proprietary platform. Every Kihealth product, every disease vertical, every revenue stream — all powered by the same compounding technology asset. The foundation for durable, capital-efficient growth across decades.
One platform. Every layer of disease interception.
Hover any layer to follow the flow of molecular data through the InterceptIQ™ platform.
A single blood draw enters the platform.
CLIA-grade workflows preserve picogram-level molecular signals.
Multi-task models calibrated against clinical ground truth.
The unified intelligence layer powering every Kihealth product.
Translating molecular intelligence into outcomes at every scale.
A family of diagnostics built on one platform.
Every product extends the same molecular intelligence engine into a new disease vertical.
Active autoimmune beta-cell injury detection for earlier identification, monitoring, and intervention.
Comprehensive beta-cell health and metabolic stress assessment before progression.
Detects molecular signals associated with pancreatic cancer at the earliest possible stage.
Identifies biological signals of Alzheimer's and related disorders before irreversible damage.
Building a platform company. Not a single-product company.
Six structural advantages that compound as the platform scales — the same playbook executed by category-defining technology and life-sciences platforms.
Platform Advantage
Every future diagnostic leverages the same molecular intelligence platform — accelerating speed-to-market and compounding clinical performance.
Scalable Economics
New products become faster and less expensive to develop as the platform expands — each indication amortizes shared R&D investment.
Shared Clinical Infrastructure
Lab, bioinformatics, clinical ops, regulatory, commercial, and AI support every vertical simultaneously.
Expanding Data Moat
Every patient strengthens the platform through proprietary longitudinal molecular datasets — network effects in clinical truth.
Multiple Revenue Streams
Clinical diagnostics, research, clinical trials, pharma partnerships, companion Dx, population screening, employer programs, licensing, international, AI software.
Capital Efficient Expansion
Each new disease indication expands value without rebuilding infrastructure — capital efficiency that traditional diagnostics companies cannot match.
From core platform to commercial application.
A purpose-built technology stack engineered for scale — regulatory, payer, and enterprise-ready from day one.
Applications
InterceptIQ™ AI Platform
Proprietary Data & Technology
Patient & Healthcare System
One of the largest opportunities in modern healthcare.
Every InterceptIQ™ vertical attaches the platform to a multi-billion-dollar market — and every Kihealth company multiplies the addressable opportunity.
Earlier detection. Better decisions. Improved outcomes — at scale.
From reactive cost center to predictive value engine.
Healthcare's largest cost burdens come from late-stage disease. InterceptIQ™ shifts the economics — predicting and preventing disease before it becomes the system's biggest expense.
Reactive Medicine
- 01Reactive Medicine
- 02Symptom-Based Care
- 03Laboratory Confirmation
- 04Treatment
InterceptIQ™
- 01InterceptIQ™
- 02Continuous Molecular Monitoring
- 03AI Prediction
- 04Risk Stratification
- 05Earlier Intervention
- 06Prevention
- 07Improved Outcomes
One platform. Multiple high-value verticals.
Every company expands the addressable market.
The Kihealth ecosystem transforms a single core diagnostic platform into multiple high-value, disease-specific businesses. Each portfolio company expands the commercial opportunity, strengthens the proprietary data network, and increases the long-term value of the overall platform — creating multiple paths to growth while leveraging the same underlying technology.
One platform.
Multiple diseases.
Global impact.
Today
Tomorrow
Building the operating system for the future of precision healthcare.
Request the corporate overview or speak with our investor relations team.
Kihealth is a privately held company. This page contains forward-looking statements regarding our platform, pipeline, regulatory plans, and financing activities. Actual results may differ materially.